As of Jul 02
| -0.53 / -3.08%|
The 3 analysts offering 12-month price forecasts for Sorrento Therapeutics Inc have a median target of 20.00, with a high estimate of 33.00 and a low estimate of 17.00. The median estimate represents a +19.90% increase from the last price of 16.68.
The current consensus among 3 polled investment analysts is to Buy stock in Sorrento Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.